Millennium Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.3M Buy
878,157
+71,121
+9% +$1.24M 0.01% 1311
2025
Q1
$10.2M Sell
807,036
-132,242
-14% -$1.66M 0.01% 1509
2024
Q4
$9.91M Buy
939,278
+452,532
+93% +$4.77M ﹤0.01% 1570
2024
Q3
$7.06M Buy
+486,746
New +$7.06M ﹤0.01% 1764
2023
Q4
Sell
-1,097,525
Closed -$4.15M 4507
2023
Q3
$4.15M Sell
1,097,525
-101,931
-8% -$385K ﹤0.01% 2013
2023
Q2
$8.04M Buy
1,199,456
+950,044
+381% +$6.37M ﹤0.01% 1617
2023
Q1
$1.62M Buy
249,412
+217,711
+687% +$1.42M ﹤0.01% 2691
2022
Q4
$270K Sell
31,701
-317,579
-91% -$2.7M ﹤0.01% 3955
2022
Q3
$1.84M Sell
349,280
-105,771
-23% -$558K ﹤0.01% 2922
2022
Q2
$1.93M Buy
+455,051
New +$1.93M ﹤0.01% 2922
2022
Q1
Sell
-595,259
Closed -$3.96M 5613
2021
Q4
$3.96M Sell
595,259
-358,432
-38% -$2.39M ﹤0.01% 2432
2021
Q3
$9.52M Buy
953,691
+944,661
+10,461% +$9.43M 0.01% 1544
2021
Q2
$279K Sell
9,030
-27,722
-75% -$857K ﹤0.01% 4547
2021
Q1
$1.6M Sell
36,752
-129,287
-78% -$5.64M ﹤0.01% 2960
2020
Q4
$7.69M Buy
+166,039
New +$7.69M 0.01% 1578